Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. (HKSE: 1099) is trading at HK$14.88, about ₹182 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.20% today. Indian residents can buy Sinopharm Group from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$14.61
Today's high
HK$14.94
52 week low
HK$14.60
52 week high
HK$22.34
1099 opened at HK$14.94, closed previously at HK$14.91, and has traded between HK$14.60 and HK$22.34 over the past 52 weeks.
About
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Key statistics
Avg. volume
5.66M
Market cap
HK$46.44B
P/E Ratio
5.65
Price-to-sales ratio
0.07
Enterprise value
CN¥111.57B
Free cash flow yield
47.12%
Debt-to-equity ratio
1.34
Return on equity
8.33%
ROIC
5.57%
Beta
0.44
Dividend yield
5.31%
Last dividend
HK$0.79
Financial overview
Revenue
CN¥575.17B
Earnings per share
CN¥2.29
Free cash flow
CN¥12.52B
Net profit margin
1.24%
Gross margin
7.03%
EBITDA
CN¥19.26B
Revenue growth
-1.60%
Similar securities
This is not an investment recommendation
How to buy Sinopharm Group from India
Indian residents can buy Sinopharm Group shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Sinopharm Group and place an order
Find Sinopharm Group by name or by its ticker, 1099, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Sinopharm Group trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Sinopharm Group position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Sinopharm Group from India
Trading and taxes when buying Sinopharm Group from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Sinopharm Group’s current yield is 5.31%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Sinopharm Group stock?
Yes. Sinopharm Group (1099) has been listed on the Hong Kong Stock Exchange since 2009, in the Medical - Distribution industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Sinopharm Group share cost in rupees?
One Sinopharm Group share is HK$14.88 — about ₹182 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Sinopharm Group price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Sinopharm Group from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Sinopharm Group?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Sinopharm Group shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Sinopharm Group price. Paasa issues a capital-gains statement for your return.
Does Sinopharm Group pay a dividend, and how is it taxed in India?
Yes. Sinopharm Group pays a dividend and the current yield is 5.31%; the last declared dividend was HK$0.79 per share, about ₹9.67. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Sinopharm Group from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Sinopharm Group a Hong Kong SAR China company, and does that change how it is taxed?
Sinopharm Group trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Sinopharm Group trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Sinopharm Group shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Sinopharm Group holding, its cost and its closing value.
How do I sell Sinopharm Group and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.